Janet LeeHead of Cell Line Development at Samsung BiologicsSpeaker
Profile
Janet Lee is the Head of Cell Line Development at Samsung Biologics. Her group has developed over 60 CLD projects successfully including complex biologics.
She has over 25 years of biologics drug development experience specializing in cell line development & upstream manufacturing process development from global biotech companies in the U.S. She joined Samsung Biologics in 2015 as a MSAT scientist and led a variety of tech transfer programs for key commercial biologics.
Agenda Sessions
Optimizing Charge Variant Profiles of mAbs Through Targeted Media and Additive Screening During Upstream Process Development
, 12:50pmView Session